Claims for Patent: 8,729,338

Summary for Patent: 8,729,338

Title:	Method of modifying the carbohydrate content of a plant
Abstract:	A method of modifying at least one carbohydrate in a tissue of a plant is described. The method is typically applied to a sugarcane plant of the genus Saccharum method and includes the steps of inserting into a plant cell a gene silencing cassette which includes nucleic acid operably linked to transcription elements such as a monocotyledonous promoter for transcribing the nucleic acid in a plant cell, wherein transcription of the nucleic acid decreases activity of UMP synthase. The method further includes the steps of regenerating a transgenic plant from the plant cell and producing the tissue with increased carbohydrate content. Vectors for use therefor, as well as a transformed plant cell and a transgenic plant or plant part containing or derived from a transformed plant cell are also described.
Inventor(s):	Boussiengui-Boussiengui; Gino (Libreville, GA), Kossmann; Jens (Somerset West, ZA)
Assignee:	Stellenbosch University (Stellenbosch, ZA) South African Sugarcane Research Institute (Mouth Edgecombe, ZA)
Application Number:	13/496,468
Patent Claims:	1. A method of increasing the sucrose content in one or more plant cells of a sugarcane plant, a sweet sorghum plant, or a sugar beet plant, the method comprising inserting into said one or more plant cells at least one exogenous nucleic acid, wherein the at least one exogenous nucleic acid comprises: (i) at least 20 nucleotides of an antisense sequence of a uridine monophosphate synthase (UMPS) open reading frame (ORF): (iii) at least 20 nucleotides of a sense sequence of a UMPS ORF: and/or (iii) (i) as above, and (ii) as above, optionally with a spliceable intron sequence between (i) and (ii), and wherein the spliceable intron sequence is at least 70 by in length and the nucleotide sequence of (i) and the nucleotide sequence of (ii) are complementary to one another, thereby increasing the sucrose content in said sugarcane plant, said sweet sorghum plant, or said sugar beet plant. 2. The method according to claim 1, wherein the at least one exogenous nucleic acid is comprised in at least one gene silencing cassette. 3. The method according to claim 2, wherein the at least one gene silencing cassette is inserted into a population of cells of a sugarcane plant, a sweet sorghum plant, or a sugar beet plant. 4. The method according to claim 1, wherein a transgenic plant is regenerated from the one or more plant cells comprising said exogenous nucleic acid. 5. The method according to claim 1, wherein the method further comprises producing tissue having increased sucrose content from the one or more transformed cells of said sugarcane plant, said sweet sorghum plant, or said sugar beet plant. 6. A method of increasing the sucrose content in tissue of a sugarcane plant, a sweet sorghum plant, or a sugar beet plant, the method comprising producing one or more transformed cells of a sugarcane plant, a sweet sorghum plant, or a sugar beet plant according to the method of claim 1 and producing a tissue from said plant cells, wherein said tissue has increased sucrose content. 7. The method according to claim 6, wherein one or more transgenic plants are regenerated from the transformed cell of the sugarcane plant, the sweet sorghum plant, or the sugar beet plant. 8. The method according to claim 6 wherein the plant tissue is a callus. 9. The method according to claim 2, wherein the exogenous nucleic acid comprised in said at least one gene silencing cassette is operably linked to one or more transcription elements for transcribing the nucleic acid in the one or more plant cells. 10. The method according to claim 1, wherein the at least one exogenous nucleic acid comprises: (i) a nucleotide sequence at least 95% similar to the nucleotide sequence of SEQ ID NO:1; (ii) a nucleotide sequence at least 95% similar to the nucleotide sequence of SEQ ID NO:2; and/or (iii) (i) as above, and (ii) as above, optionally with a spliceable intron sequence between (i) and (ii), and wherein the spliceable intron sequence is at least 70 by in length and the nucleotide sequence of (i) and the nucleotide sequence of (ii) are complementary to one another. 11. The method according to claim 9, wherein the UMPS ORF corresponds to the UMPS ORF of the transformed plant cell. 12. The method according to claim 1, wherein two or more gene silencing cassettes are inserted into said one or more plant cells of a sugarcane plant, a sweet sorghum plant, or a sugar beet plant. 13. The method according to claim 9, wherein the one or more transcription elements comprise a promoter. 14. The method according to claim 13 wherein the promoter is a monocotyledonous promoter. 15. The method of claim 2, wherein the one or more gene silencing cassettes are comprised in a vector. 16. The method according to claim 15, wherein the vector is an RNAi vector comprising an intron containing hairpin RNA ihpRNA. 17. The method according to claim 15, wherein the at least one exogenous nucleic acid is operably linked to one or more transcription elements for transcribing the nucleic acid. 18. A transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell, wherein the plant, plant part or cell comprises at least one exogenous nucleic acid comprising: (i) at least 20 nucleotides of an antisense sequence of a uridine monophosphate synthase (UMPS) open reading frame (ORF); (ii) at least 20 nucleotides of a sense sequence of a UMPS ORF; and/or (iii) (i) as above, and (ii) as above, optionally with a spliceable intron sequence between (i) and (ii), and wherein the spliceable intron sequence is at least 70 by in length and the nucleotide sequence of (i) and the nucleotide sequence of (ii) are complementary to one another. 19. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 18, wherein the at least one exogenous nucleic acid is comprised in at least one gene silencing cassette. 20. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 18, wherein the exogenous nucleic acid is operably linked to one or more transcription elements for transcribing said nucleic acid and said exogenous nucleic acid is comprised in one or more gene silencing cassettes. 21. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 18, wherein the nucleic acid comprises: (i) a nucleotide sequence at least 95% similar to the nucleotide sequence of SEQ ID NO:1; (ii) a nucleotide sequence at least 95% similar to the nucleotide sequence of SEQ ID NO:2; and/or (iii) (i) as above, and (ii) as above, optionally with a spliceable intron sequence between (i) and (ii), and wherein the spliceable intron sequence is at least 70 by in length and the nucleotide sequence of (i) and the nucleotide sequence of (ii) are complementary to one another. 22. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 20, wherein the one or more transcription elements comprise a promoter. 23. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 22, wherein the promoter is a monocotyledonous promoter. 24. A plant comprising or derived from the transformed plant, plant part or plant cell of the sugarcane plant, a sweet sorghum plant, or a sugar beet plant of claim 18. 25. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 19, wherein the at least one expression cassette is comprised in a vector. 26. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 18, wherein the transformed plant part is a callus. 27. The transformed sugarcane plant, sweet sorghum plant, sugar beet plant, plant part, or plant cell according to claim 25, wherein the vector is an RNAi vector comprising ihpRNA.

Details for Patent 8,729,338

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2029-09-17
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2029-09-17
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2029-09-17